Home > Catalogues

Cambridge City over - 75s Cohort Study (The) [CC75C] Download as PDF

GENERAL INFORMATION

Name Cambridge City over - 75s Cohort Study (The)
Acronym CC75C
Last update 07/22/2009

Affiliation

Principal investigators

Carol Brayne (Professor of Public Health Medicine/Prof.)
University of Cambridge, Department of Public Health and Primary Care
Felicia A Huppert (Reader in Psychology/Dr)
University of Cambridge, Department of Psychiatry
Tom R Dening (Medical Director/Dr)
Cambridgeshire & Peterborough Mental Health Partnership NHS Trust
Eugene S Paykel (Professor of Psychiatry (retired)/Prof)
University of Cambridge, Department of Psychiatry

Contacts

Jane Fleming (Research Nurse and Study Co-ordinator/Dr)
University of Cambridge, Department of Public Health and Primary Care
Cambridge CB2 0SR
Phone: +44 (0) 1223 330341
Email: jane.fleming@phpc.cam.ac.ukMail
Emily Zhao (Computer Officer/Ms.)
University of Cambridge, Department of Public Health and Primary Care
Cambridge CB2 0SR
Phone: +44 (0) 1223 330341
Email: ez219@medschl.cam.ac.ukMail

Website

Funding agency

Percentage Category
Dementia and Neurodegenerative Diseases Research Network -- Public funding
The BUPA Foundation -- Charity
National Institute for Health Research, UK -- Public Funding

BACKGROUND

The Cambridge City over-75s Cohort Study (CC75C) is a long-term follow-up study of a representative population sample of 2,166 people aged 75 and older, begun in 1985.
The study’s origins lie in a survey of dementia prevalence, the Hughes Hall Project for Later Life, which began in 1985 and its first follow-up dementia incidence study, the Cambridge Project for Later Life. The first study targeted all men and women aged 75 or older who were registered with geographically and socially representative general practices in Cambridge, and achieved a 95% response rate. From this original survey of 2,610 people, 2,166 individuals form the baseline sample for the longitudinal cohort which excluded one of the original general practices because of differential recruitment and a sub-group involved in a branch study. It is the survivors from this group – now known as the Cambridge City over-75s Cohort – who have been followed up on at least six further occasions, with sub-groups assessed more often, and those nonagenarians and centenarians still alive now continuing to be followed up. Through a series of interviews and assessments spanning over 20 years the participants have contributed to one of the largest and longest-running longitudinal observational studies of ageing into older old age. The biological collection includes blood samples collected at Year 10 and an on-going brain donation programme.

OBJECTIVES

The study’s core themes – cognition and function in older old age – cover multidisciplinary research interests as diverse as neuropsychology, genetics, palliative care and psychiatry with a range of investigations at various time-points including bone strength, falls, physical performance and brain pathology. Each survey has included a detailed cognitive assessment. The combination of biological (neuropathological and genetic) data and life factors measured longitudinally in a population-based sample allow examination of how these factors interact to bring about the clinical manifestations of cognitive impairment and dementia.

Topics of interest

  • No Broad approach with no specific topic of interest
  • Yes Target specific topics of interest (health outcomes, health determinants, etc.)
Topics ICD-10 classificationExternal
Yes Mental and behavioural disorders (F00-F99)
Yes Diseases of the nervous system (G00-G99)

METHODS

Legend Yes No Unknown

General design

Study design Cohort
Type of participants Individuals
Target or final number of participants 2166
Target or final number of DNA 406

Participant selection / Characteristics of the population

Selection criteria

Yes Age Minimun: 75 years   
Yes Country of residence United Kingdom (Cambridge)

Recruitment procedures

Participants were initially identified through primary care registers - all men and women aged 75 or older registered with geographically and socially representative general practices. Letters outlining the study allowed the opportunity to refuse before one of the research team visited in person to explain in more detail and obtain consent. Interviews were conducted in the participant’s usual place of residence.

Data Sources

  Cross-sectional Repeated/continuous
Yes Questionnaires to participants/respondents No Yes
Yes Direct physical measures Yes No
Yes Biological samples Yes No
Unknown Medical paper
Unknown Electronic databases
Unknown Genealogical records  

Collection procedures

Each survey has included the Cambridge Cognitive Examination (CAMCOG), a detailed cognitive assessment that includes the Mini-Mental State Examination (MMSE). Sub-samples have had detailed psychiatric assessment using the Cambridge Diagnostic Examination for the Elderly (CAMDEX) interview, detailed neuropsychological assessment and additional tests. Longitudinal data are also available on socio-demographic variables (e.g. change of residence, household structure, change in marital status, social contact), activities of daily living, use of health and social services, health problems and medication. Biological resources collected include blood and saliva samples, whilst the brain donation programme has made it possible to undertake neuro-pathological and molecular biological analyses on tissue from a representative sample of elderly people. Functional performance testing and heel ultrasound measurements of bone fragility were introduced in the sixth interview wave, which also included a year's prospective falls data collection. The focus of the seventh survey is on quality of life issues at the end of life for which we are currently interviewing relatives or carers of about fifty surviving members of the cohort all now aged 95 or more, as well as these study participants themselves.

Follow up procedures

Follow-up surveys have been every few years.

Baseline principal variables of interest

Health information

  • No Diseases history - ICD-10
  • No Medication intake
  • No Familial disease history
  • No Early life
  • No Women's health
  • No Quality of life

Physical / Biochemical measures

No Body structure measures No Biochemical measures
No Body function measures  

Sociodemographic Characteristics

Yes Gender
Yes Marital status Yes Date of birth

Socioeconomic Characteristics

Yes Education level No Income
Yes Working status  

Life habits / Behaviours

No Physical activity No Smoking / Tobacco Use
No Nutrition No Alcohol intake

Physical environment

No Passive smoking No Mobile phone use

Sample management

Biological samples

Yes Blood Unknown Buccal cells
No Cord blood Yes Tissues (Brain tissues)
Unknown Saliva Unknown Urine

Biological samples format

  Fresh Frozen Dried (paper) Other Specification
Blood No Yes No No
Tissues No Yes   No Yes (Brain tissues)

Genome-Wide Association (GWA) analyses

  • Yes Plan to proceed to GWA analyses later

GOVERNANCE

Legend Yes No

Allow access to data or samples to external researchers

Academia Industry
Yes Data (questionnaire-derived, measured…) Yes
Yes Biological samples Yes

STATUS

Current status

Phase Start End
Preparation phase/Pilot -- --
Recruitment / initial data collection 1985 1987
Follow-up of participants 1985 --
Current number of participants recruited 2166
Current number of collected DNA samples 406

blood and/or brain tissue

Participation rate 95% in date of 01/01/1987

AVAILABLE DOCUMENTS

  Document type Availability
1 General study protocol
2 Specific protocols/procedures (data collection, samples management, etc.) jane.fleming@phpc.cam.ac.ukMail
3 Questionnaires
4 Consent forms
5 Governance / ethics documentation jane.fleming@phpc.cam.ac.ukMail

PUBLICATIONS AND RELEVANT DOCUMENTATION

Publication url

http://www.cc75c.group.cam.ac.uk/pages/journals/default.htmExternal

COMMENT

Following variables of interest are not collected at baseline but in subsequent surveys:
- Diseases history;
- Medication intake;
- Quality of life;
- Anthropometric measures;
- Physical activity;
- Smoking/Tobacco use;
- Alcohol intake.


General information

Name Physical and cognitive measures
Last update 07/27/2010
Collected at phase MMSE, Self reported physical condition and ADL were measured in all surveys

Contacts

Jane Fleming (Research Nurse and Study Co-ordinator/Dr)
Cambridge CB2 0SR
Phone: +44 (0) 1223 330341
Email: jane.fleming@phpc.cam.ac.ukMail

Physical and cognitive measures collected

Legend Yes No

BODY STRUCTURES

ANTHROPOMETRIC STRUCTURES

Anthropometric measures

Yes Weight (Survey 3-Survey 7: Have you lost or gained al lot of weight in the last six month)

Yes Height (Survey 6)

Yes Standing height

Body composition

Yes Others body composition measures (Survey 6: Quantitative ultrasound heel scans.)

BODY FUNCTIONS

MENTAL FUNCTIONS

Global mental functions

Yes Cognitive functions (MMSE scores, full CAMCOG and CAMDEX interviews.)

Specific mental functions

Yes Attention functions

Yes Memory functions

Yes Psychomotor functions

SENSORY FUNCTIONS AND PAIN

Seeing and related functions

Yes Vision and related functions (Survey1 - 7: self report poor vision. Survey 4-6 survey 6: Vision test.)

Hearing and vestibular functions

Yes Hearing (Survey 1 -7: Self report poor hearing. Survey 4-6: Hearing test.)

VOICE AND SPEECH FUNCTIONS

Fluency and rhythm of speech functions

Yes Speech fluency (Survey 1 - 7: Interviewer assessment on unclear speech.)

NEUROMUSCULOSKELETAL AND MOVEMENT-RELATED FUNCTIONS

Yes Grip strength (Survey 6)

Yes Sit and reach (Reaching up to comb hair or down to cut toenails)

Yes Other measures of the neuromusculoskeletal system and movement-related function (survey 6: Short Physical Performance Battery, including balance tests, gait speed, and chair stands)

OTHER BODY FUNCTIONS

Other measures of the body functions

ADL questions

ACTIVITIES AND PARTICIPATIONS

LEARNING AND APPLYING KNOWLEDGE

Yes Learning (In survey 1 only: how old when lft wchool. How many years on further training.)

Administration mode

Legend Yes No

Administration environment

No Hospital, clinic, university or recruitment center

Yes Participant residence

No Other

Staff administering test

Yes Professionals (nurses, clinicians, etc)

Yes Interviewers/research assistants

No Other

Documentation on procedures

Administration language English

General Information

Name Information Technologies
Study name Cambridge City over - 75s Cohort Study (The) [CC75C]
Last update 02/22/2010

Contact

Emily Zhao (Computer Officer/Ms.)
Institute of Public Health, University of Cambridge
Cambridge CB2 0SR
Phone: +44 (0) 1223 330341
Email: ez219@medschl.cam.ac.ukMail

Software

Legend Yes No

Biobanking areas covered

  • No Participant recruitment (ex: CATI, CRM)
  • No Data collection
  • No Questionnaires (ex: CAPI)
  • No Physical and cognitive measures
  • Yes Sample collection, storage and processing
  • No Collection
  • No Sample bio-repository management system (ex: sample storage management software)
  • Yes LIMS (ex: biochemical analysis, DNA extraction, genotyping)
  • Yes Data repository
  • Yes Data warehousing
  • Yes Study monitoring (ex: quality control)
  • No User data / sample request management

Internal/external development

  • No In-house by IT department
  • Yes By an external company (STATA)

Shareability

  • No Freely available
  • Yes Purchaseable
  • No Needs extensive work
  • No Not for share

Comments

No information available

© 2005 Public Population Project in Genomics.
All rights reserved.
Information Usage